from Yahoo Finance https://ift.tt/2YXxVPV
-
LabCorp expands availability of at-home sample collection kit for COVID-19 testing
from Yahoo Finance https://ift.tt/2T1fHcN
-
U.S. FDA declines to review Bristol Myers, bluebird therapy for multiple myeloma
from Yahoo Finance https://ift.tt/2WUgWeC
The Latest
-
5 ASX 200 shares with 33% to 61% upside post-results: experts
-
Why this ASX healthcare share is a retiree’s dream for FY27
-
Up 88%! Why CSL shares remain an ‘appealing’ buy today
-
Endeavour shares fell 12% last week. Is the CEO calling the bottom?